Afghanistan vs Uganda: The number of people with susceptibility test result for rifampicin
Afghanistan
70.58
in 2021
Uganda
74.76
in 2021
Afghanistan rank
103rd
Uganda rank
101st
The number of people with susceptibility test result for rifampicin over time
- Afghanistan
- Uganda
How they compare
Uganda currently reports 74.76 against 70.58 in Afghanistan, a difference of 4.18.
That makes Uganda's figure about 1.1 times Afghanistan's.
Across all 5 years both countries report, Uganda has been ahead every year.
Afghanistan ranks 103rd and Uganda ranks 101st of 146 countries.
Uganda has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 28.75 | 82.7 | 53.95 | Uganda |
| 2020s | 57.72 | 68.69 | 10.96 | Uganda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Afghanistan or Uganda?
- Uganda, at 74.76 against 70.58 in Afghanistan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Afghanistan and Uganda?
- 4.18, with Uganda ahead.
- How many years of comparable data are there for Afghanistan and Uganda?
- 5 years are reported by both, from 2017 to 2021.
- How do Afghanistan and Uganda rank globally for the number of people with susceptibility test result for rifampicin?
- Afghanistan ranks 103rd and Uganda ranks 101st of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.